Step change of mobile phase flow rates to enhance protein folding in size exclusion chromatography

Minimal aggregation formation between injector and column inlet and enough residence time inside the column were identified to be the key for proper proteins refolding by size exclusion chromatography (SEC). Therefore, a step change of mobile phase flow rate strategy was developed. That is, during the injected denatured protein (sample) traveling from injector to column inlet, a higher rate of mobile phase should be applied to reduce aggregation. Then, a lower flow rate should be used to allow enough time for protein to refold inside the column. The refolding of denatured lysozyme in SEC by this method was shown to reduce the aggregation and thus resulting in good refolding yields, though not completely. Combining this method together with our previously proposed chaperon solvent plug strategy could obtain complete recovery of denatured protein, both mass and activity recoveries.

[1]  Z. Su,et al.  In vitro protein refolding by chromatographic procedures. , 2004, Protein expression and purification.

[2]  Z. Su,et al.  Urea gradient size-exclusion chromatography enhanced the yield of lysozyme refolding. , 2001, Journal of chromatography. A.

[3]  X Y Dong,et al.  Lysozyme refolding with immobilized GroEL column chromatography. , 2000, Journal of chromatography. A.

[4]  U. Rinas,et al.  Renaturation of heterodimeric platelet-derived growth factor from inclusion bodies of recombinant Escherichia coli using size-exclusion chromatography. , 1999, Journal of chromatography. A.

[5]  Julian B. Chaudhuri,et al.  Refolding of Low Molecular Weight Urokinase Plasminogen Activator by Dilution and Size Exclusion Chromatography—A Comparative Study , 2000 .

[6]  M. Ladisch,et al.  Chromatography for Rapid Buffer Exchange and Refolding of Secretory Leukocyte Protease Inhibitor , 1996, Biotechnology progress.

[7]  J. Chaudhuri,et al.  Refolding and purification of a urokinase plasminogen activator fragment by chromatography. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[8]  J. Chaudhuri,et al.  Effect of column dimensions and flow rates on size-exclusion refolding of beta-lactamase. , 2003, Journal of biochemical and biophysical methods.

[9]  Zhiguo Su,et al.  Refolding human lysozyme produced as an inclusion body by urea concentration and pH gradient ion exchange chromatography , 2002 .

[10]  Zhiguo Su,et al.  Inhibition of aggregation by media selection, sample loading and elution in size exclusion chromatographic refolding of denatured bovine carbonic anhydrase B. , 2003, Journal of biochemical and biophysical methods.

[11]  Hwai-Shen Liu,et al.  Chaperon solvent plug to enhance protein refolding in size exclusion chromatography , 2003 .

[12]  Julian B. Chaudhuri,et al.  Refolding & Purification Of A Ukrinase Plasminogen Activator Fragment By Chromotography , 2001 .

[13]  E D Clark,et al.  Protein refolding for industrial processes. , 2001, Current opinion in biotechnology.

[14]  T. Ueda,et al.  Effective renaturation of reduced lysozyme by gentle removal of urea. , 1995, Protein engineering.

[15]  Guifeng Zhang,et al.  Dual gradient ion-exchange chromatography improved refolding yield of lysozyme. , 2002, Journal of chromatography. A.

[16]  J. Chaudhuri,et al.  Protein refolding at high concentration using size‐exclusion chromatography , 1996, Biotechnology and bioengineering.

[17]  James R. Swartz,et al.  Polyethylene Glycol Enhanced Protein Refolding , 1992, Bio/Technology.

[18]  D. Hevehan,et al.  Oxidative renaturation of lysozyme at high concentrations. , 1997, Biotechnology and bioengineering.

[19]  Z. Su,et al.  Refolding of superoxide dismutase by ion-exchange chromatography , 2002, Biotechnology Letters.

[20]  R. Jaenicke,et al.  A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme. , 1991, Biochemistry.

[21]  J. Chaudhuri,et al.  Molecular characterisation of size exclusion chromatography refolded urokinase-plasminogen activator , 2001 .